MoneyWorks4Me

Guj. Inject (Kerala) - Quaterly Results

09 May 2024 Evaluate
Revenue showed a marginal decline at Rs. 54.19 millions. For the quarter ended March 2024, as compared to corresponding quarter of last year.The Net Profit of the company vaulted to 533.33% to Rs. 0.38  millions from Rs. 0.06 millions in the previous quarter.Operating profit for the quarter ended March 2024 rose to 0.45 millions as compared to 0.08 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 54.19 0.00 0.00 57.88 1.74 3226.44 57.88 1.74 3226.44
Other Income 0.00 0.30 -100.00 0.61 4.32 -85.88 0.61 4.32 -85.88
PBIDT 0.45 0.08 462.50 1.06 0.55 92.73 1.06 0.55 92.73
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 0.45 0.08 462.50 1.06 0.55 92.73 1.06 0.55 92.73
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.45 0.08 462.50 1.06 0.55 92.73 1.06 0.55 92.73
TAX 0.07 0.02 250.00 0.22 0.14 57.14 0.22 0.14 57.14
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.38 0.06 533.33 0.84 0.41 104.88 0.84 0.41 104.88
Equity 112.92 48.85 131.16 112.92 48.85 131.16 112.92 48.85 131.16
PBIDTM(%) 0.83 0.00 0.00 1.83 31.61 -94.21 1.83 31.61 -94.21
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..